AGILENT TECHNOLOGIES, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
AGILENT TECHNOLOGIES, INC. (A) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $42.00 million for the 12-month period ending 2025-10-31, per its 10-K filed 2025-12-22.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-12-22
- AGILENT TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-10-31 was $6.00M.
- AGILENT TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-07-31 was $4.00M.
- AGILENT TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-04-30 was $13.00M.
- AGILENT TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-01-31 was $14.00M.
- AGILENT TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $42.00M, a 30.00% decline from fiscal 2024.
- AGILENT TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $60.00M, a 14.29% decline from fiscal 2023.
- AGILENT TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $70.00M.
- AGILENT TECHNOLOGIES, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2020 was $37.00M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-10-31 | $42.00M 10-K · filed 2025-12-22 | |||
| 2024-10-31 | $60.00M 10-K · filed 2025-12-22 | |||
| 2023-10-31 | $70.00M 10-K · filed 2025-12-22 | |||
| 2022-10-31 | $38.00M 8-K · filed 2025-03-03 | |||
| 2021-10-31 | $53.00M 8-K · filed 2024-09-03 | |||
| 2020-10-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-21 | $10.00M derived: sum of 2 quarters · filed 2022-12-21 | $23.00M derived: sum of 3 quarters · filed 2022-12-21 | $37.00M 10-K · filed 2022-12-21 |
| 2020-07-31 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-09-01 | $17.00M derived: sum of 2 quarters · filed 2020-09-01 | $31.00M 10-Q · filed 2020-09-01 | |
| 2020-04-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-06-01 | $27.00M 10-Q · filed 2020-06-01 | ||
| 2020-01-31 | $14.00M 10-Q · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |